June 3, 2010 – OxySure® Systems, Inc., a manufacturer and pioneer of innovative emergency/short duration respiratory solutions, announced the Company was awarded a multi-year contract by the General Services Administration (GSA) to supply its products to all branches of the US Federal Government. The Company’s Federal Supply Schedule Contract number V797P-4153b is unrestricted, or a 100% set-aside contract for small business, and has an initial term ending November 14, 2013. Thereafter, the contract may be renewed for up to 3 additional 5-year terms. Federal buyers will be able to purchase OxySure products immediately, either directly from OxySure or via GSA Advantage!®, the US government’s online shopping and ordering system.
GSA awards contracts to responsible companies offering commercial items, at fair and reasonable prices. OxySure is a trusted emergency oxygen solution and has been approved and validated by third parties such as the FDA, UT Austin, Southwest Research Institute, and North Texas Enterprise Center for Medical Technology, and has hundreds of documented cases of saved lives... [PDF] OxySure Systems' Press Release -
Blog Archive
-
▼
2010
(63)
-
▼
June
(13)
- FDA Approves Merck's DULERA® Inhalation Aerosol f...
- Palatin Technologies : Positive Preclinical Data w...
- Merck Serono Resumes Stimuvax Clinical Program in ...
- Zargis to Launch FDA-Cleared Lung Sounds Analysis ...
- Rational Therapeutics : Metastatic NSCLC Survival ...
- Clovis Oncology & Avila Therapeutics : $209 Millio...
- OxySure : GSA Contract
- Revotar Biopharmaceuticals : Phase II Clinical Tri...
- Sandoz : acquisition of Oriel Therapeutics, streng...
- Oncimmune : Studies Demonstrate Early Stage Detect...
- Verona Pharma : AGM Statement
- Deep Breeze : FDA CLEARS UNIQUE NON-INVASIVE, RADI...
- Centocor Ortho Biotech Acquires RespiVert Strength...
-
▼
June
(13)